MedPath

Daily Bi-temporal Transcranial Random Noise Stimulation in Tinnitus

Not Applicable
Completed
Conditions
Chronic Tinnitus
Interventions
Device: Transcranial random noise stimulation (tRNS)
Registration Number
NCT01965028
Lead Sponsor
University of Regensburg
Brief Summary

Stimulation of the left and right auditory cortex with daily transcranial random noise stimulation (tRNS) is used to modulate the neural pathways involved in chronic tinnitus.

Detailed Description

Tinnitus is the phantom auditory perception of sound in the absence of an external or internal acoustic stimulus. It is a frequent problem which can interfere significantly with the ability to lead a normal life. Tinnitus has been shown to be generated in the brain, as a result of functional reorganization of auditory neural pathways and the central auditory system. These changes are represented by hyper-activity and hyper-synchronicity in the auditory pathway. Treatment remains difficult. Non-invasive brain stimulation methods has shown to be effective in the treatment of chronic tinnitus with moderate effect size. Preliminary data presented on international conferences suggest the use of transcranial random noise stimulation (tRNS) over both auditory cortices as new and highly effective treatment. High-frequency (hf; 100-650Hz) tRNS might be highly effective in tackling hyper-synchronised cell assemblies. Daily Hf-tRNS (2 weeks) will be examined with regard to feasibility, safety and clinical efficacy in patients suffering from chronic tinnitus in an one-arm pilot trial.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
30
Inclusion Criteria
  • Diagnosis of bothersome, subjective chronic tinnitus
  • Diagnosis: Duration of tinnitus more than 6 months
Read More
Exclusion Criteria
  • Objective tinnitus
  • Irregular head shap below the electrodes
  • Eczema on the head
  • Treatable cause of the tinnitus
  • Involvement in other treatments for tinnitus at the same time
  • Clinically relevant psychiatric comorbidity
  • Clinically relevant unstable internal or neurological comorbidity
  • History of or evidence of significant brain malformation or neoplasm, head injury
  • Cerebral vascular events
  • Neurodegenerative disorder affecting the brain or prior brain surgery
  • Metal objects in and around body that can not be removed
  • Pregnancy
  • Alcohol or drug abuse
Read More

Study & Design

Study Type
INTERVENTIONAL
Study Design
SINGLE_GROUP
Arm && Interventions
GroupInterventionDescription
Transcranial random noise stimulation (tRNS)Transcranial random noise stimulation (tRNS)High frequency tRNS (Neuroconn, Eldith DC-Stimulator Plus): 100-650Hz, 2mA, 20min, 10s ramp time, left and right auditory cortex, 5x7cm electrode with the inferior middle part over T3/T4
Primary Outcome Measures
NameTimeMethod
Number of treatment responders (response: Tinnitus Questionnaire total score reduction ≥ 5, contrast baseline versus end of treatment/week 12)Week 12
Secondary Outcome Measures
NameTimeMethod
Change of tinnitus severity as measured by the Tinnitus QuestionnaireWeek 12
Change of tinnitus severity as measured by the Tinnitus Numeric Rating ScalesWeek 12
Change of depressive symptoms as measured by the Major Depression InventoryWeek 12
Change in quality of life as measured by the WHOQoL-BrefWeek 12

Trial Locations

Locations (1)

University of Regensburg - Dept of Psychiatry

🇩🇪

Regensburg, Germany

© Copyright 2025. All Rights Reserved by MedPath